Every 8-K that ModivCare Inc. (MODV) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow MODV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MODV filings page.
ModivCare Inc. announced that director David Mounts Gonzales resigned from its Board, effective November 9, 2025. The company stated his departure was not due to any disagreement regarding operations, policies, or practices.
As trading context, at the opening of business on August 28, 2025, the company’s common stock was suspended from Nasdaq and began being quoted on the Expert Market operated by OTC Markets Group under the symbol MODVQ. Nasdaq filed a Form 25‑NSE on October 1, 2025 to delist the common stock and remove it from registration under Section 12(b).
ModivCare Inc. disclosed it commenced voluntary Chapter 11 bankruptcy proceedings on August 20, 2025 and received Nasdaq notices that it is no longer suitable for listing and is delinquent in regulatory filings. Nasdaq determined to commence delisting proceedings and informed the company the common stock would be suspended at the opening of business on August 28, 2025. The company does not intend to appeal and expects Nasdaq to file to remove the listing, after which the stock may quote on the OTC Pink market, though that is not assured.
ModivCare Inc. (MODV) commenced voluntary Chapter 11 cases on August 20, 2025, and entered a Restructuring Support Agreement with consenting first‑lien lenders and second‑lien noteholders to implement a court‑supervised recapitalization. The RSA contemplates $100 million of debtor‑in‑possession (DIP) financing, up to $300 million of takeback term loans at emergence, conversion of approximately $871 million of first‑lien claims into $200 million of exit debt plus ~98% pro forma equity, and conversion of ~ $316 million of second‑lien claims into ~2% pro forma equity. The plan also contemplates new warrants, a potential $200 million equity rights offering, and a $250 million revolving facility. The restructuring would reduce funded debt by about $1.1 billion. The company continues as debtor‑in‑possession, has requested customary "first day" relief, and cautions that common stockholders may suffer significant or complete loss.